Skip to main content
. 2022 Feb 17;10(2):314. doi: 10.3390/vaccines10020314

Table 15.

The seroconversion between visits V2 and V4/5.

Seroconversion Interpretation V2 Total
Interpretation V4/V5 Negative Positive
Negative 545 (99.8%) RT
78.4% CT
77.3% GT
10.2% RT
10.0% CT
0.1% GT
546 (77.4%)
Positive 150 (94.3%) RT
21.6% CT
21.3% GT
95.7% RT
90.0% CT
1.3% GT
159 (22.6%)
Total 695
(98.6%)
10
(1.4%)
705